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Amy Vandiver,1,2 Ann Zenobia Moore,7 Toshiko Tanaka,7 Luigi Ferrucci,7 M. Daniele Fallin,1,8,*
and Andrew P. Feinberg1,2,*
Epigenetic marks such as DNA methylation have generated great interest in the study of human disease. However, studies of DNA
methylation have not established population-epigenetics principles to guide design, efficient statistics, or interpretation. Here, we
show that the clustering of correlated DNAmethylation at CpGs was similar to that of linkage-disequilibrium (LD) correlation in genetic
SNP variation but for much shorter distances. Some clustering of methylated CpGs appeared to be genetically driven. Further, a set of
correlated methylated CpGs related to a single SNP-based LD block was not always physically contiguous—segments of uncorrelated
methylation as long as 300 kb could be interspersed in the cluster. Thus, we denoted these sets of correlated CpGs as GeMes, defined
as potentially noncontiguous methylation clusters under the control of one or more methylation quantitative trait loci. This type of
correlated methylation structure has implications for both biological functions of DNA methylation and for the design, analysis, and
interpretation of epigenome-wide association studies.Introduction
Epigenetic marks such as DNAmethylation have generated
great interest in the study of human disease and in epide-
miology broadly, given the potential for epigenetic media-
tion of genetic or environmental risk factors for disease
and their potential as biomarkers of exposure or disease
risk and progression.1,2 Because of this, several recent pub-
lications have examined genome-scale DNA-methylation
data through either array-based or whole-genome bisul-
fite-sequencing technologies.3–7 However, studies of DNA
methylation have not yet established population-epige-
netics principles to guide design, efficient statistics, or
interpretation. For example, SNP analyses rely on the pop-
ulation-genetics concept of linkage disequilibrium (LD) to
inform the design of custom arrays, efficient statistical
approaches such as haplotype analyses, and interpretation
of associations observed with respect to localization and
putative functional relevance.8 Epigenetic epidemiology
would benefit greatly from a similar set of population-epi-
genetics concepts.
We and others have shown that variable methylation—
across tissues within individuals or for a given tissue across
individuals in a population—tends to occur in ‘‘regions’’ of
several CpGs;9,10 however, little is currently documented
and understood about the specific genomic locations of
such ‘‘regions,’’ the amount of variability, or the spatial
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The Amwithin populations, and across populations. Because
some of the variability at particular DNA-methylation sites
is indeed dependent on genotype,6,11,12 these epigenetic
properties might parallel population-genetic properties.
However, no one to date has attempted to document this
in parallel to sequence-variation properties at a population
level. The accumulation of several recent epigenetic-epide-
miology projects using genome-scale array data, such as
the Illumina HumanMethylation450 array, in concert
with sequence information such as SNP data from
genome-wide association studies (GWASs), now makes
such description possible.6
Here, we show that the correlation of DNA methylation
at CpGs within variably methylated regions (VMRs) was
similar to the LD correlation in genetic SNP variation but
for much shorter distances when contiguous CpGs were
considered. Some clustering of methylated CpGs appeared
to be genetically driven; SNPs in LD blocks associated with
correlated methylated CpGs. Further, the set of correlated
methylated CpGs associated with a single SNP-based LD
block showed ‘‘gap’’ patterns in which segments as long
as 300 kb had uncorrelatedmethylation between segments
correlated with each other and associated with a particular
SNP signal. We termed these correlated CpGs ‘‘GeMes’’
for genetically controlled methylation clusters. Thus,
although proximal, the spatial clustering of methylation
patterns was not directly contiguous, and the structure
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genetic variants, such as methylation quantitative trait loci
(meQTLs), have been previously reported11–15 to control
CpG methylation, we conducted a genome-wide study of
GeMes at a population level. This type of correlated
methylation structure has implications for both biological
functions of DNA methylation and the design, analysis,
and interpretation of epigenome-wide associations studies
(EWASs).Material and Methods
DNA Methylation and Genotype Data
We obtained two publicly available data sets for DNAmethylation.
We used data from the Gene Expression Omnibus (GEO) for the
Illumina HumanMethylation450 array data on whole blood
(accession number GSE42861). These individuals were selected
from the Epidemiological Investigation of Rheumatoid Arthritis
(EIRA), a Swedish population-based case-control study. Only
control individuals from one batch (hybridized in 2012) were
included in these analyses. EIRA control subjects were selected
to match rheumatoid arthritis (RA [MIM 180300]) case subjects
in terms of age, gender, and residential area at the time of diag-
nosis. All individuals were of self-reported European ancestry
and did not have obvious population stratification according to
ancestry estimation from genome-wide SNP data.16 More detailed
recruitment procedure for the EIRA study was described previ-
ously.16 After exclusion of three samples that failed our quality-
control procedures, the final methylation data set included 247
individuals. The genotyping procedures for these 247 samples
have been described previously.16
We obtained the other DNA-methylation data set also fromGEO
(accession number GSE43414).17 These individuals were selected
from one cohort of the Medical Research Council London Brain
Bank for Neurodegenerative Diseases.17 After exclusion of individ-
uals who failed our quality-control procedures, the final data set
on whole blood used for replication included 91 individuals.
The Baltimore Longitudinal Study of Aging (BLSA) is an ongoing,
long-term,open-panel studyonnormalhumanaging. Studydesign
and recruitment for the BLSA have been described previously.18
Most of the participants were community-dwelling individuals
from the Washington-Baltimore area. The DNA-methylation data
were generated with the Illumina HumanMethylation450 array
according to the manufacturer’s recommendations. A total of 305
individuals of Europeandescent, as estimated via ancestry principle
components from genome-wide SNP data, were included in the
analyses. TheDNA-methylation data are available fromGEOunder
accession number GSE54882.
Initial Identification of Contiguous Methylation
Clusters
Ultimately, we recommend defining GeMes by a combination of
information about genetic control and CpG methylation correla-
tion, as described formally below. However, to initially describe
correlation patterns of CpGs at the genome level, we began with
solely contiguous definitions based on observed methylation cor-
relation alone. We used probes only on autosomes and excluded
probes containing SNPs (dbSNP v.132) at the probed CpG sites
to eliminate artifacts due to differential hybridization, resulting
in a data set of 417,457 CpGs. We estimated cell-type distribution
for each individual on the basis of his or her methylation data19486 The American Journal of Human Genetics 94, 485–495, April 3, 2and used methylation residuals after adjusting for estimated cell
proportions6 and sex. We then only focused on the top 25% of
the most variably methylated CpG sites (vCpGs) in the data set
for downstream analyses.
We defined a potential contiguous methylation cluster as con-
taining at least three neighboring vCpG sites on the Illumina
HumanMethylation450 array and having at least 50% of its vCpG
pairs showing a methylation correlation coefficient (r2) R 0.4. To
avoid biases potentially drivenbyoutliers,we performedbootstrap-
ping with sample replacement (1,000 times) and only kept the
contiguous methylation clusters present in at least 99% of all
bootstrap samples.
To identify contiguous methylation clusters after adjusting for
potential confounding by ancestry mixture, we further calculated
methylation residuals by using a linear regression model predict-
ingmethylation at each CpG site as a function of the top two prin-
cipal components of genotype data, in addition to estimated cell
proportions and gender. We then used these residuals to identify
contiguous methylation clusters as described above.
Analysis of Methylation-Correlation Decay and
Genetic-LD Decay
To determine the spatial rate of decay for vCpGs, we computed a
Pearson correlation coefficient (r2) between each pair of vCpGs.
We generated the decay-rate plot by fitting a cubic smoothing
spline of r2 against genomic distance. In the case of SNPs, we
used the software package Haploview to determine the LD correla-
tion between all pairs of SNPs. Given the density of SNPs, we
filtered to only those with a minor allele frequency (MAF) > 10%
for this genome-wide evaluation.
Enrichment of DHSs and Smoking-Associated DMPs
in Contiguous Methylation Clusters
DNase I hypersensitive sites (DHSs) are based on the manufacture
annotation file from the Illumina HumanMethylation450 array.
Twenty-six smoking-associated differentially methylated posi-
tions (DMPs) were obtained from previously published results.20
These DMPs were checked against contiguous methylation clus-
ters generated from whole blood (Tables S1 and S2, available
online). The p values for enrichment were computed with Fisher’s
exact test.
Identification of GeMes
Correlated CpG clusters, in which CpGmethylation is most likely
controlled by the same genetic signal, are designated GeMes.
These are not necessarily contiguous but are rather defined via
the following steps: (1) identify all vCpGs whose methylation
level is associated with at least one SNP within 5 Mb (i.e., identify
all statistically significant vCpG-meQTL pairs at p< 13 1013), (2)
group one or more vCpGs associated with the same SNP into a
vCpG cluster, (3) merge vCpG clusters if any of their members
share a common meQTL, (4) and retain only clusters with more
than two vCpGs. These vCpG clusters are labeled GeMes, and
we refer to all SNPs associated with any vCpG methylation in
that GeMe as a SNP cluster.
These steps were based on genome-wide association analyses for
all vCpGs to identify SNPs that might be meQTLs at each vCpG.
For this analysis, all Illumina HumanMethylation450 probes on
sex chromosomes or probes containing SNPs (dbSNP v.132) any-
where in the sequence (which might affect the interpretation of
meQTL results) were excluded, leaving 68,561 vCpGs. These014
vCpGs were subsequently tested for association with autosome
SNPs withMAF> 1% and at least ten individuals in each genotype
group in these data (total 609,162 SNPs) via an additive minor-
allele dosage model. vCpG-SNP associations were corrected for
multiple testing with a stringent Bonferroni-adjusted threshold
of 1 3 1013 (<0.05 / (68,561 3 60,9162) ¼ 1.20 3 1012). Cis-
meQTLs were then identified for sets of genome-wide significant
vCpG-SNP pairs (or vCpG-specific meQTLs), in which the distance
between the vCpG and SNP was less than 5 Mb.
Enrichment of GWAS SNPs among meQTLs and
GeMes
The GWAS SNP set used for analysis was derived from the National
Human Genome Research Institute (NHGRI) Catalog of Published
GWASs21 and was processed as described previously.22 The
p values for enrichment were computed with Fisher’s exact test.
Bisulfite Pyrosequencing
To replicate the relationship between GeMes and GWAS SNPs at
the FADS1 (MIM 606148)-FADS2 (MIM 606149) and GSDMA
(MIM 611218)-GSDMB (MIM 611221) regions, we selected an in-
dependent set of 90 EIRA healthy individuals for the experiment.
We bisulfite converted 200 ng of genomic DNA from each sample
with an EZ DNA Methylation-Gold Kit (ZYMO Research) accord-
ing to the manufacturer’s recommendations. We amplified bisul-
fite-converted genomic DNA by PCRwith unbiased nested primers
and carried out quantitative pyrosequencing to measure DNA
methylation at each CpG site with a PSQ HS96 (Biotage). The per-
centage of DNA methylation was determined with Pyro Q-CpG
methylation software (Biotage). Genomic DNA amplified by the
REPLI-g Mini Kit (QIAGEN) was used as the nonmethylated DNA
control, and SssI-treated genomic DNA was used as the 100%
methylation control. Different percentage mixtures containing
nonmethylated and 100% methylated controls were also used as
25%, 50%, and 75% methylation controls. Genomic coordinates
and primer sequences for all bisulfite-pyrosequencing reactions
are provided in Table S3.
Analysis Software
All analyses were performed in R 2.15 and Bioconductor 2.9.
Illumina HumanMethylation450 array data were analyzed with
the ‘‘minfi’’ package.Results
Genome-Level Spatial Correlation of DNA
Methylation versus LD
To initially compare methylation structure to SNP struc-
ture in genetic studies, we first examined the observed
correlation in DNA-methylation data generated from
Illumina HumanMethylation450 arrays on whole-blood-
derived DNA from 247 healthy individuals from the
EIRA study.6,16 We focused on the top 25% of CpG sites
with the largest methylation variation (vCpGs) because
these are epigenetic variants informative for methylation
studies, just as polymorphic SNPs are for genetic studies.
Of these vCpGs, 41,772 could be separated into 9,836
regions containing at least three contiguous variable
probes, a pattern similar to what we observed previouslyThe Amas VMRs.9,10 Figure 1A shows a typical pattern of DNA
methylation in a region where there is variable methyl-
ation between individuals and spatial correlation in
methylation levels within individuals (Figures 1A and 1B).
These patterns could be seen at the chromosome and
genome level. Figure 1C shows a heat map of the pairwise
correlation in DNA-methylation levels across a 1 Mb re-
gion of chromosome 9, where there was clearly clustering
of highly spatially correlated vCpGs. Similar to patterns
of LD, such patterns tended to show decay in correlation
strength with increasing distance and existed regardless
of epigenetic annotation, such as CpG islands, shores, or
open seas (Figure 1D). However, the length of these contig-
uous methylation clusters appeared to be much shorter
than that of LD blocks—the methylation correlation was
reduced by half in less than 500 bp, whereas SNP-based
LD correlation was reduced by half in approximately 3 kb
in these same individuals (Figures 1D and 1E), although a
direct comparison between SNP-based LD-correlation
decay and spatial-methylation decay is difficult given the
density of the 450K array. This does demonstrate, however,
that the normal human methylome includes groups of
CpGs that vary coordinately in the population.
To examine the locations and patterns of these contigu-
ously correlated methylation sites, we began with a
working definition of a contiguous methylation cluster
according to rules similar to those applied for defining
LD blocks23 (see Material and Methods). In our 247 sam-
ples, and on the basis of 450K array density, we identified
2,100 contiguous methylation clusters (Table S1), contain-
ing a total of 8,491 vCpG sites. To evaluate the biological
relevance of these contiguous methylation clusters, we
then checked the enrichment of DHSs, given that DHSs
mark accessible chromatin regions for active transcrip-
tion.22,24 Compared to the 450K array background, the
proportion of DHS-located CpGs that were also in a contig-
uous methylation cluster showed a 1.89-fold enrichment
(Table S4). This enrichment was further increased to
2.17-fold when we changed the definition of a contiguous
methylation cluster to include at least five vCpG sites
(Table S4), implying that areas of contiguous methylation
clusters might be relevant areas of accessible epigenome.
We replicated these results in two additional data sets. In
the first, containing DNA-methylation data from Illumina
HumanMethylation450 array for 91 whole-blood-derived
DNA samples17 (GEO accession number GSE43414), we
identified 2,434 contiguous methylation clusters, contain-
ing a total of 10,099 vCpG sites (Table S2); of these, 6,875
(81.0%) CpG sites overlapped with our primary data sets
(Figure S1). With the same approach, we also identified
2,334 contiguous methylation clusters, containing a total
of 9,518 vCpG sites, from a third data set (the BLSA) (Table
S2); of these, 7,550 (88.9%) CpG sites overlapped with our
primary data set (Figure S1).
Although the blood-derived contiguous-methylation-
cluster patterns were consistent across three independent
samples, it is possible that these correlation patternserican Journal of Human Genetics 94, 485–495, April 3, 2014 487
Figure 1. Clustering of Correlated Methylated CpGs
(A) An example of a contiguousmethylation cluster identified on chromosome 9. Each line shows the smoothedmethylation residual of
one individual with the use of the smooth.spline function from R. A random 50 individuals was plotted here for easy visualization.
(B) Detailed DNA-methylation levels among populations for the CpG sites within the contiguousmethylation cluster shown in (A). Each
row represents the methylation residual of one individual, and each column represents a different CpG site. Values of methylation
residuals range from low (blue) to high (green) on the color scale.
(C) DNA-methylation correlation for the contiguous methylation cluster shown in (A). The ticks in the top panel represent CpG sites
that were covered in the arrays. The bottom panel shows a zoomed-in heatmap image of the region indicated in the top panel. The
measure of the correlation coefficient (r2) of methylation residuals among all possible pairs of CpGs is shown graphically according
to the shade of red; gray represents low r2, and red represents high r2. Probes from identified contiguous methylation clusters are
highlighted in red.
(D) Plot of the decay rate of r2 against the distance for DNAmethylation on vCpG sites. Different color lines represent probes of different
vCpG context from the Illumina HumanMethylation450 arrays.
(E) Plot of the correlation decay for genetic variants (black line) or for DNA methylation (red line).represent the effects of common underlying confounders,
such as ancestry mixtures. We thus evaluated the potential
confounding by ancestry mixtures by performing contig-
uous-methylation-cluster analysis with methylation resid-
uals after further adjusting for the top two principal
components of genotype data, the surrogate measure-
ments of ancestry mixtures,25 and noticed that almost all
the contiguous methylation clusters (99%) from our pri-
mary data set were still present after ancestry adjustment
(Figure S2).
Smoking-Associated DMPs Are Enriched in
Contiguous Methylation Clusters
Given the interest in DNA methylation and environ-
mental exposures,20,26–28 particularly the growing associa-
tions with smoking,20,29 we examined whether variation at488 The American Journal of Human Genetics 94, 485–495, April 3, 2these contiguous methylation clusters was associated with
these factors and whether such correlated regions were
enriched with smoking associations. We observed that 16
of 26 smoking-associated DMPs20 were present in contig-
uous methylation clusters identified from our primary
data set (Table 1); this represented a 30.26-fold enrichment
in comparison to the 450K array background (p value <
2.2 3 1016) (Table S5). The enrichment of smoking-
associated DMPs in contiguous methylation clusters was
also observed in the other two replication data sets (Table
S5). This implies that the epigenome susceptible to
environmental exposures might be enriched with contig-
uous methylation clusters and that focus on spatially
correlated units such as contiguous methylation clusters
might be particularly efficient for environmental epige-
netic analyses.014
Table 1. Smoking DMPs Are Enriched in Contiguous Methylation
Clusters
CpG Chr Gene
Contiguous
Methylation Clusters
cg05575921 5 AHRR no
cg05549655 15 CYP1A1 yes
cg11924019 15 CYP1A1 yes
cg09935388 1 GFI1 yes
cg12876356 1 GFI1 yes
cg18316974 1 GFI1 yes
cg09662411 1 GFI1 yes
cg25949550 7 CNTNAP2 no
cg06338710 1 GFI1 yes
cg04180046 7 MYO1G yes
cg04598670 7 ENSG00000225718 no
cg23067299 5 AHRR no
cg18146737 1 GFI1 yes
cg12803068 7 MYO1G yes
cg14179389 1 GFI1 no
cg22549041 15 CYP1A1 yes
cg18092474 15 CYP1A1 yes
cg19089201 7 MYO1G no
cg22132788 7 MYO1G yes
cg10399789 1 GFI1 yes
cg21161138 5 AHRR no
cg03991871 5 AHRR no
cg12477880 21 RUNX1 yes
cg03346806 8 EXT1 no
cg18655025 14 TTC7B no
cg11715943 6 HLA-DPB2 yes
The following abbreviation is used: chr, chromosome.GeMes: Potentially Noncontiguous Genetically
Controlled Methylation Clusters
Considering previous reports of genome-wide existence
of meQTLs,11–15 we next sought to determine the rela-
tionship between contiguous methylation clusters and
genotype at a population level by examining whether
methylation correlation in clusters is driven by genetic var-
iants. We identified 24,887 vCpG-SNP pairs in which the
DNA methylation level was significantly associated with
genotype (p value < 1.0 3 1013). When visualized graph-
ically, many of these vCpG-SNP association pairs formed
clusters where a distinct group of vCpGs were controlled
by a distinct group of SNPs. In these occasions, the methyl-
ation levels of the vCpGs controlled by the same group of
SNPs were correlated, and this might have been the origin
of some of the observed methylation correlation in contig-
uous methylation clusters (Figure 2A). Interestingly, weThe Amnoticed that some distinct methylation clusters, as previ-
ously defined by contiguous spatial rules, were associated
with the same underlying SNP cluster but were not
spatially defined as a single cluster because uncorrelated
vCpGs existed between them (Figure 2A). Methylation
levels among all vCpGs controlled by the same SNP cluster
were mostly correlated and would have been defined as a
single spatial cluster if the vCpGs in between had not
been measured (Figure 2B shows a correlation plot
collapsed from Figure 2A to include only CpGs controlled
by the SNP cluster). Thus, we considered these potentially
noncontiguous genetically controlled methylation clus-
ters, GeMes.
In order to identify GeMes across the genome, we
expanded our genotype-methylation association analysis
by using all 104,365 individual vCpGs, i.e., not starting
with the contiguous correlated CpGs but rather excluding
any 450K probes containing SNPs because theymight have
affected the measurement of DNA methylation. This re-
sulted in a data set composed of 609,162 SNPs and
68,561 vCpGs. We then identified the individual vCpGs
that were associated with SNPs, i.e., the meQTLs.11–15
We identified 97,658 vCpG-SNP pairs in which the
DNA-methylation level was significantly associated with
genotype (meQTLs; p value < 1.0 3 1013) (Table S6).
Among these vCpG-SNP pairs, 91,589 (93.8%) of the
CpGs lay < 5 Mb from the associated SNP (Figure S3), sug-
gesting that the majority of genetically influenced methyl-
ation was controlled through cis-regulation, similar to
what has been reported (cis-meQTLs).11–15 These vCpG-
SNP pairs comprised 5,919 unique vCpGs and 52,170
unique SNPs. We then separated vCpG clusters to include
any vCpGs controlled by any SNP in a distinct group of
cis-meQTLs so that each genotype-controlled methylation
cluster contained an independent set of vCpGs and cis-
meQTLs. We identified a total of 3,404 such clusters, in
which the average number of SNPs for each cluster was
15.3 and the average number of vCpGs was 1.7 (Table
S7). Of these clusters, 1,019 contained at least two vCpG
sites, defined as GeMes. Using this expanded definition,
we note that some of them now included additional rela-
tively distant vCpGs, which had not been identified from
the previous contiguous definitions (Figures 2C and 2D),
suggesting that the structure of GeMes is not simply based
on spatial patterns. For example, in Figure 2C, CpG sites
more than 300 kb away (C3 and C5) are in the same
GeMe, even though SNPs near the former CpG site (C3)
do not control its methylation level and further are not
in LD with the associated SNP cluster.
To confirm the finding of GeMes, we replicated the find-
ings in the BLSA data set for 50 randomly chosen GeMes
from our primary data set, plus the two examples shown
in Figures 2A and 2C.We tested whether DNA-methylation
levels were controlled by the same group of SNPs. These
52 GeMes contained 991 CpG-SNP pairs with both
genotype and methylation information in the BLSA. The
associations between genotype and methylation wereerican Journal of Human Genetics 94, 485–495, April 3, 2014 489
Figure 2. GeMes: Genetically Controlled Methylation Clusters
(A and C) Examples of GeMes on chromosomes 21 (A) and 1 (C). In the middle panels, each dashed line represents a significant asso-
ciation between a CpG and a SNP. The shades of black for these lines indicate significance of the associations. The ticks represent CpGs
(top) and SNPs (bottom) that were covered in the arrays. Identified CpG probes whose methylation levels are controlled by genotype are
indicated and highlighted in red. The methylation correlation (top panels) and genetic-LD correlation (bottom panels) for all the probes
covered in the region are shown correspondingly. The measure of the correlation coefficient of the methylation level, as well as the
genetic-LD correlation, is shown graphically according to the shades of red; gray represents low r2, and red represents high r2.
(B and D) Plots of detailed DNA-methylation levels, as well as their correlations, are shown; (B) is collapsed from (A) and (D) is collapsed
from (C) to include only sites on GeMes. Bottom panels: each row represents the methylation residual of one individual, and each
column represents a different CpG site whose location is indicated and highlighted in (A) or (C). Values of DNA-methylation residuals
range from low (blue) to high (green) on the color scale. Top panels: the measure of the correlation coefficient of the methylation level
for the corresponding CpG sites.
(E) Associations between CpG sites and SNPs upstream of (top panel), within (middle panel), or downstream of (bottom panel) themajor
histocompatibility complex (MHC) region. Each dashed line represents a significant association, and the shades of black indicate signif-
icance of the associations.replicated in the 984 pairs (99.3%) with a Bonferroni-
adjusted p value < 0.05 (Figure S4).
Given the complex and elongated LD structure of the
major histocompatibility complex (MHC) region on chro-
mosome 6, we examined the vCpG-SNP structure in that
region. In the MHC region, there were clear vCpG-SNP
clusters connected over small distances (similar to Figures
2A and 2C) but also SNP connections to the same vCpGs
across distinct LD blocks (Figure 2E). This complex pattern
of genetic control of methylation might inform genetic
associations in this region6 and might help to localize sig-
nals more precisely than LD associations can resolve.
Relationship between GeMes and GWASs
Given that SNPs were found to control GeMes and that
clusters of methylated CpGs are smaller than LD blocks,
we examined whether incorporating CpG-methylation490 The American Journal of Human Genetics 94, 485–495, April 3, 2data with GWAS SNP-association data could help us better
understand the functional effects of genome-wide associa-
tions. We first examined the enrichment of 5,654 non-
coding disease-associated SNPs from the NHGRI Catalog
of Published GWASs (5,134 unique SNPs)21,22 among
the SNPs we found associated with DNA methylation
(meQTLs). Among 2,336 GWAS-identified SNPs avail-
able in our study, 322 were meQTLs, representing a
1.61-fold enrichment in comparison to all available SNPs
(p value¼ 5.123 1014). This is consistent with others’ ob-
servations that GWAS SNPs are enriched among certain
functionally annotated categories30 and suggests that
SNPs associated with disease might be related to epigenetic
mechanisms.
We then performed the same analysis but limited it
to the 1,019 GeMes in which the same SNP cluster con-
trolled at least two vCpG sites. We observed a 1.86-fold014
Figure 3. Implications for Disease-Asso-
ciated SNPs
(A) SNPs controlling DNA methylation in
meQTLs or GeMes were enriched in
GWAS variants (overall), and this enrich-
ment was phenotypic-class specific. Grey
bars represent SNPs associated with DNA-
methylation levels (meQTLs), and black
bars represent SNPs associated with
GeMes. Asterisks indicate significant en-
richment of GWAS variants in comparison
to all available SNPs (p value < 0.01,
Fisher’s exact test).
(B and C) Two selected examples (the
FADS1-FADS2 region in B and the
GSDMA-GSDMB region in C) in which
identifying GeMes controlled by GWAS
SNPs might help in fine mapping the vari-
ants important for disease phenotype. The
GWAS variants identified from other
studies are indicated in red. The ticks
represent CpGs (top) and SNPs (bottom)
covered in the arrays. Each dashed line rep-
resents a significant association between a
CpG and a SNP. The shades of black indi-
cate significance of the associations.enrichment for these SNP in comparison to all available
SNPs (p value ¼ 1.39 3 1013); this was further enhanced
when we considered all meQTLs, although the difference
between GeMe enrichment and meQTL enrichment was
just outside the range of statistical significance (p value ¼
0.07; Figure 3A). When we considered GWAS SNPs on
the basis of their phenotypic classes, the largest enrich-
ment groups were in autoimmune diseases, serum metab-
olites, and hematological parameters. For these, GeMe
enrichment was higher than meQTLs enrichment, and
the difference between them achieved statistical signifi-
cance for autoimmune diseases (p value¼ 0.03; Figure 3A),
consistent with the fact that we identified these GeMes
from whole blood. This result indicates that these GeMes
might be epigenetically relevant units in interpreting dis-
ease-associated SNPs.The American Journal of HumaSeveral examples highlight the
potential utility of GeMes for better
understanding GWAS data. A SNP on
chromosome 11 (rs102275) is associ-
ated with circulating phospholipid
levels and proportions,31,32 whereas
a different SNP (rs174448) 100 kb
away is associated with plasma phos-
pholipid n-3 fatty-acid levels.33 By
analyzing CpGs whose methylation
levels are regulated by genotypes,
we noticed that both SNPs, even
though they belong to separate LD
blocks (r2 < 0.5, CEU [Utah residents
with ancestry from northern and
western Europe from the CEPH collec-
tion] population in HapMap), wereassociated with the same GeMe near the promoter
regions of genes FADS1 and FADS2 (Figure 3B), which are
members of the fatty-acid desaturase gene family. This
might enhance interpretation and understanding of these
GWAS signals. As another example, SNP rs2872507 is asso-
ciated with Crohn disease (CD [MIM 266600]),34 whereas a
different SNP (rs9303277) 50 kb away is associated with
primary biliary cirrhosis (PBC [MIM 109720]).35 SNPs
within this region control the DNA-methylation level of
a GeMe near the promoter regions of genes GSDMA and
GSDMB (Figure 3C), indicating that DNA methylation
might be important for disease mechanism. In fact, an
earlier report showed that the disease-associated genetic
variants are linked with changes in expression of GSDMB
transcripts in human lymphoblastoid cell lines,36 further
suggesting that DNA methylation potentially mediatesn Genetics 94, 485–495, April 3, 2014 491
genetic risk for CD and PBC. More examples can be seen in
Figure S5. To further replicate the relationship between
GWAS SNPs and DNA-methylation levels at GeMes at the
FADS1-FADS2 and GSDMA-GSDMB regions, we performed
bisulfite pyrosequencing on an independent set of 90
normal individuals. The associations between genotype
and methylation were replicated at all eight tested SNP-
CpG pairs with a p value < 0.05 (Figure S6). These results
suggest that DNA-methylation information can help us
fine map the genetic variants that might be responsible
for the disease phenotype and that investigating these
DNA-methylation sites might help us better understand
disease mechanisms.Discussion
In summary, we have observed clustering of correlated
methylation sites that vary in the population, and this
clustering represents a new type of epigenetic structure.
Some clusters of methylated CpGs, termed GeMes, are
driven by one or more meQTLs and can result in non-
contiguous methylation clustering. Thus, the spatial
clustering of methylation patterns is not directly con-
tiguous, and the structure is most likely controlled by
DNA sequence. Even though genetic variants, such as
meQTLs, have been previously reported to control CpG
methylation,11–15 our genome-wide study has shown the
structures of DNA methylation, GeMes, at a population
level.
These methylation structures were found by examina-
tion of the Illumina HumanMethylation450 array, and
the data described here are subject to the same limitations
of interpretation of any data from this source; these limita-
tions include (1) potential batch effects,37 which we
addressed by comparing across data sets; (2) limitations
and coverage bias of the array themselves, which limit
the ability to quantify objectively the number or distribu-
tion of methylation clusters; and (3) the lack of allele-spe-
cific measurements, which require whole-genome bisulfite
sequencing with particularly long-read sequencing to
include genetic polymorphisms within the methylation
reads38 in a large population. Regarding the third point,
this is the same problem as in assigning phase information
to SNPs from array data, and the imputation of phase de-
pends on a large body of pre-existing knowledge, which
does not yet exist for DNA methylation. In fact, a recent
study analyzed five targeted regions in a reasonably large
number of samples with the added advantage of long-
range 454 sequencing, permitting statements about
allele-specific DNA methylation.39 This work is highly
consistent and, in fact, would represent what we are now
calling GeMes here. With our genome-wide identification
of GeMes, it will be interesting to see how many of these
are allele specific.
There are other considerations regarding our approach
to identifying correlatedmethylation regions. For example,492 The American Journal of Human Genetics 94, 485–495, April 3, 2to be most comparative with SNP-based LD, we initially
used the statistical approach from population genetics of
pairwise associations to define contiguous methylation
clusters. An alternative approach uses ‘‘bump hunting’’
to identify VMRs in data from comprehensive high-
throughput array-based relative methylation without re-
gard for directional correlation,10 but we would expect
VMRs to largely overlap with contiguous methylation clus-
ters. A test of this idea will require generation of similar
algorithms for 450K data.
Further, there is an alternative explanation for the find-
ings we describe. The SNPs driving GeMes might in fact be
driving subtle cell-type differences, perhaps those that
cannot be defined with cell-surface markers, and/or cell
differentiation. The association with SNPs could be related
to those driving cell-type proportion,40–43 which might
also explain the enrichment of hematological parameters
and autoimmune disease in GWASs. Arguing against this
idea is the fact that most of such loci did not overlap our
SNPs associated with GeMes. Another argument against
this is that 94% of the vCpG-SNP pairs we identified
were located within 5 Mb of each other, which is inconsis-
tent with the idea that a SNP that drives cell-type propor-
tion should be associated with many cell-type-associated
differentially methylated regions across the genome.
Even if that were the case, the regional nature of the clus-
ters, particularly at a distance, would be of biological
interest (but for the mechanism of normal development
rather than for disease).
With these limitations in mind, however, several reason-
able inferences can be made from these analyses. First,
DNA methylation is correlated over regions with a
median length of 274 bp from our data set an order of
magnitude less than is SNP association. This rapid decay
in DNA-methylation correlation is similar to what has
been observed in wild Arabidopsis thaliana accessions,12
and DNA-methylation dependency over short regions is
consistent with a recent study on bisulfite sequencing of
several loci with haplotype-dependent methylation.39
However, what is different here is the examination of a
large number of individuals showing that the methylation
codependency itself varies across the genome and thus rep-
resents a kind of related epigenetic unit—a counterpart to
LD blocks but with very different potential mechanisms.
Similar to LD blocks in GWASs, this type of correlated
methylation structure can be a useful tool for guiding
custom array design, efficient statistical approaches, and
interpretation of EWASs.
Second, some GeMes skip genomic regions to include
sites at considerable genomic distance (more than 300 kb
in some cases) but are apparently controlled by the same
genetic architecture. This is a surprise, especially given
that correlated methylation sites at a large distance can
be under the influence of SNPs at one end of the interval
while skipping vCpG-SNP combinations in the middle.
The most plausible explanation for these data is that
GeMes have a structural basis in nuclear organization,014
i.e., the DNA is looped within interacting domains,44
which will require future studies.
Third, methylation clusters can also reflect differences in
environmental exposure and not genotype, such as smok-
ing here. Thus, environmental agents might act to modify
nuclear structure, potentially in collaboration with genetic
variation, affecting the regulation of genes in contiguous
or even noncontiguous regions.
Fourth, these data suggest that a potential component of
GWAS disease association acts in partnership with epige-
netic mechanisms. Even with a small number of DNA-
methylation data sets on a limited portion of the genome,
i.e., 450K, 8% of positive GWAS associations appear to
converge on GeMes. This number will only increase with
similar analyses using data from whole-genome bisulfite
sequencing. At the very least, these results suggest that a
more productive genomic research target for association
studies might be the GeMes described here.
In summary, despite inherent limitations to this study,
GeMes should provide a useful tool in the design and anal-
ysis of GWASs, combining conventional GWASs with tar-
geted epigenome analysis. Such an approach might allow
higher resolution than what is possible for the analogous
SNP associations by themselves, given that regardless of
mechanism, the sites of SNP-linked GeMes appear to
bridge genomic regions and focus attention on small
methylation regions within much larger LD blocks.Supplemental Data
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